PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis

Title:PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis

Volume: 16 Issue: 9

Author(s): Joshua Holcomb, Nicholas Spellmon, Laura Trescott, Fei Sun, Chunying Li and Zhe Yang

Affiliation:

Keywords: CFTR, cystic fibrosis, drug design, NHERF1/2, PDZ, structure.

Abstract: PDZ domains play an essential role in a number of cellular processes by facilitating protein scaffolding and assembly of protein complexes. These domains consist of 80 to 90 amino acids and are found to recognize short C-terminal sequences of target proteins. Protein complex formation between PDZ target molecules can lead to a number of signaling and regulatory cascades that may either promote or inhibit the activation of certain proteins. It has been shown that the interaction of the PDZ domains of NHERF2 with LPA₂ plays an inhibitory role on the cystic fibrosis transmembrane conductance regulator (CFTR) by promoting the assembly of a CFTR–NHERF2–LPA₂ complex. CFTR regulates chloride ion transport across the epithelial plasma membrane, and individuals possessing CFTR mutations show decreased protein function and consequently, viscous mucus accumulation due to improper fluid transport. This type of ailment is termed cystic fibrosis. Thus, insight to the structure of PDZ domains and how they function to form macromolecular complexes could be therapeutically important in augmenting CFTR channel activity in cystic fibrosis patients. Here we review the PDZ domain family while dissecting their structure, function and implications in CFTR regulation and cystic fibrosis.

Cite this article as:

Holcomb Joshua, Spellmon Nicholas, Trescott Laura, Sun Fei, Li Chunying and Yang Zhe, PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis, Current Drug Targets 2015; 16 (9) . https://dx.doi.org/10.2174/1389450116666141219120125